Cyclosporin A Associated Helicase-Like Protein and Hepatitis C Virus Replication
Author Information
Author(s): Morohashi Kengo, Sahara Hiroeki, Watashi Koichi, Iwabata Kazuki, Sunoki Takashi, Kuramochi Kouji, Takakusagi Kaori, Miyashita Hiroki, Sato Noriyuki, Tanabe Atsushi, Shimotohno Kunitada, Kobayashi Susumu, Sakaguchi Kengo, Sugawara Fumio
Primary Institution: Genome and Drug Research Center, Tokyo University of Science, Noda, Chiba, Japan
Hypothesis
The study investigates the role of a cellular protein, CAHL, in the replication of the hepatitis C virus (HCV) and its interaction with cyclosporin A.
Conclusion
The study identifies CAHL as a crucial factor in HCV replication, forming a complex with CyPB and NS5B, and suggests that targeting CAHL could be a potential strategy for HCV treatment.
Supporting Evidence
- CAHL was identified as a novel target protein for cyclosporin A through phage display screening.
- Downregulation of CAHL resulted in decreased HCV genome replication.
- CAHL forms a complex with HCV RNA polymerase NS5B and cyclophilin B, which is essential for HCV replication.
Takeaway
Researchers found a protein that helps the hepatitis C virus make copies of itself, and this protein can be affected by a drug called cyclosporin A.
Methodology
The study used phage display screening to identify CAHL and analyzed its interactions with HCV proteins through various biochemical assays.
Limitations
The study does not explore the full range of cellular factors involved in HCV replication and the potential effects of other drugs.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website